CURIS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
CURIS, INC. (CRIS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $575.91 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $37.64, a 138.08% increase year-over-year.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $15.81, a 79.86% decline year-over-year.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $78.49, a 1907.42% increase year-over-year.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $3.91, a 53.40% decline year-over-year.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $13.21, a 71.17% decline from fiscal 2024.
- CURIS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $45.82.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $575.91 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $37.64 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $13.21 10-K · filed 2026-03-24 | |||
| 2025-09-30 | $14.17 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $10.57 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | $15.81 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $45.82 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $45.82 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $46.58 10-Q · filed 2024-08-01 | |||
| 2024-03-31 | $78.49 10-Q · filed 2024-05-07 | |||
| 2023-09-30 | $66.10 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $3.35 10-Q · filed 2023-08-03 | |||
| 2023-03-31 | $3.91 10-Q · filed 2023-05-04 | |||
| 2022-09-30 | $5.74 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $7.29 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | $8.39 10-Q · filed 2022-05-05 | |||
| 2021-09-30 | $11.76 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $11.54 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $11.05 10-Q · filed 2021-05-12 | |||
| 2020-09-30 | $2.79 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | $2.89 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $7.52 10-Q · filed 2020-05-12 | |||
| 2019-09-30 | $7.95 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $7.76 10-Q · filed 2019-08-09 | |||
| 2019-03-31 | $8.70 10-Q · filed 2019-05-14 | |||
| 2018-09-30 | $10.14 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $11.59 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $2.08 10-Q · filed 2018-05-03 | |||
| 2017-09-30 | $2.44 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | $2.90 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $3.10 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |